Document is current

Article History

Received: 27 December 2022

Accepted: 6 March 2023

First Online: 26 March 2023

Declarations

:

: The study has been approved by an ethics committee (Comité de Protection des Personnes Ouest VI, CPP Ouest 6 – CPP 1194 ME1) and patients will be included after informed consent, next of kin consent, or an emergency procedure with patient deferred consent.

: Not applicable.

: AF reports honoraria by Fisher & Paykel for a lecture during SFMU Congress 2022, outside the submitted work.AWT reports financial support (payment for lectures and travel expenses coverage to attend scientific meetings) by Fisher & Paykel, GE Healthcare, and Philips, all outside the submitted work.AMD reports grants from Fischer Paykel, and personal fees from Air Liquide and Addmedica, all outside the submitted work.TS reports personal fees from ADEP assistance, AstraZeneca France, Boehringer Ingelheim France, Chiesi France, Lungpacer Inc, Novartis France, and Vitalaire (over the past 3 years), all outside the submitted work.PA and SL declare that they have no competing interests.AD reports grants from the French Ministry of Health, Assistance publique – Hôpitaux de Paris, Lungpacer, Respinor; consulting fees from Respinor, Lungpace, Lowenstein, Tribunal administratif de Cergy, Liberate Medical; payment or honoraria for lectures, presentations from Fisher & Paykel, Baxter, Getinge, Astra, Agence Européenne Informatique, Mindray; and support for attending meetings and/or travel from Lungpacer, outside the submitted work.